MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/1060028017753480

Медицинская библиотека · The Annals of pharmacotherapy · 2018

Sedative Plasma Concentrations and Delirium Risk in Critical Illness.

Stollings Joanna L, Thompson Jennifer L, Ferrell Benjamin A, Scheinin Mika, Wilkinson Grant R, Hughes Christopher G, Shintani Ayumi K, Ely E Wesley, Girard Timothy D, Pandharipande Pratik P, Patel Mayur B

СтатьяРандомизированное исследованиеПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПоддержка правительства СШАПеревод в очереди

Аннотация

BACKGROUND

The relationship between plasma concentration of sedatives and delirium is unknown.

OBJECTIVE

We hypothesized that higher plasma concentrations of lorazepam are associated with increased delirium risk, whereas higher plasma concentrations of dexmedetomidine are associated with reduced delirium risk.

METHODS

This prospective cohort study was embedded in a double-blind randomized clinical trial, where ventilated patients received infusions of lorazepam and dexmedetomidine. Plasma concentrations of these drugs and delirium assessments were measured at least daily. A multivariable logistic regression model accounting for repeated measures was used to analyze associations between same-day plasma concentrations of lorazepam and dexmedetomidine (exposures) and the likelihood of next-day delirium (outcome), adjusting for same-day mental status (delirium, coma, or normal) and same-day fentanyl doses.

RESULTS

This critically ill cohort (n = 103) had a median age of 60 years (IQR: 48-66) with APACHE II score of 28 (interquartile range [IQR] = 24-32), where randomization resulted in assignment to lorazepam (n = 51) or dexmedetomidine (n = 52). After adjusting for same-day fentanyl dose and mental status, higher plasma concentrations of lorazepam were associated with increased probability of next-day delirium (comparing 500 vs 0 ng/mL; odds ratio [OR] = 13.2; 95% CI = 1.4-120.1; P = 0.02). Plasma concentrations of dexmedetomidine were not associated with next-day delirium (comparing 1 vs 0 ng/mL; OR = 1.1; 95% CI = 0.9-1.3; P = 0.45).

CONCLUSIONS

In critically ill patients, higher lorazepam plasma concentrations were associated with delirium, whereas dexmedetomidine plasma concentrations were not. This implies that the reduced delirium risk seen in patients sedated with dexmedetomidine may be a result of avoidance of benzodiazepines, rather than a dose-dependent protective effect of dexmedetomidine.

Для цитирования: Stollings Joanna L, Thompson Jennifer L, Ferrell Benjamin A, Scheinin Mika, Wilkinson Grant R, Hughes Christopher G, Shintani Ayumi K, Ely E Wesley, Girard Timothy D, Pandharipande Pratik P, Patel Mayur B. Sedative Plasma Concentrations and Delirium Risk in Critical Illness.. The Annals of pharmacotherapy. 2018. DOI: 10.1177/1060028017753480.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.